Anders Hove Insider Profile
4 Followers
Anders Hove, Director at Oruka Therapeutics, holds 1.54M shares in Oruka Therapeutics (Ticker: ORKA), holds 359.42K shares in Anacor Pharmaceuticals (Ticker: ~ANAC), holds 3.95M shares in Alimera (Ticker: ALIM).
Anders Hove's Trading History
| ORKAOruka Therapeutics | Feb 21, 2017 | Director | Uninformative Buy | ― | $162.38M | |
| ~ANACAnacor Pharmaceuticals | Jun 24, 2016 | ― | Uninformative Sell | 3.36M | $35.61M | |
| ALIMAlimera | Apr 27, 2010 | ― | Informative Buy | 3.37M | $21.88M |
You May Also Like
Anders Hove insider profile FAQ
What is the percentage of profitable transactions made by Anders Hove?
The percentage of profitable transactions made by Anders Hove is 100%.
What is the average return per transaction made by Anders Hove?
The average return per transaction made by Anders Hove is 40.30%.
What stocks does Anders Hove hold?
Anders Hove holds: ORKA, ~ANAC, ALIM stocks.
What was Anders Hove's most profitable transaction?
Anders Hove’s most profitable transaction was an Informative Sell of ~ANAC stock on December 15, 2015. The return on the trade was 42.70%.
What is Anders Hove's role in Oruka Therapeutics?
Anders Hove's role in Oruka Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
